Boston Scientific to Webcast Conference Call Discussing Second Quarter 2017 Financial Results

Share this story

NEWS PROVIDED BY Boston Scientific Corporation 08:30 ET

MARLBOROUGH, Mass.July 5, 2017 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the second quarter ended June 30, 2017 on Thursday, July 27, 2017 at 8:00 a.m. EDT. The call will be hosted by Mike Mahoney, chairman and chief executive officer, and Dan Brennan, executive vice president and chief financial officer. The company will issue a news release announcing financial results for the second quarter on Thursday, July 27, 2017, prior to the conference call.

A live webcast of the conference call will be available on the Investor Relations section of the website at investors.bostonscientific.com. Interested parties are encouraged to register at least 15 minutes prior to the scheduled start time to ensure a timely connection.

A replay of the webcast will be archived and available at www.bostonscientific.com/investors beginning approximately one hour following the completion of the meeting.

About Boston Scientific

Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 35 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.

CONTACTS

Media:                                            

Investors:

Emily Anderson                              

Susie Lisa, CFA

508-683-6305 (office)                        

508- 683-5565 (office)

Media Relations                               

Investor Relations

Boston Scientific Corporation              

Boston Scientific Corporation

Emily_Anderson2@bsci.com              

investor_relations@bsci.com

 

SOURCE Boston Scientific Corporation

Leave a Comment

Your email address will not be published. Required fields are marked *

*